Terms: = Kidney tumors AND ETV5, P41161, 2119, ENSG00000244405, ERM
14 results:
1. Effect of Two Cystatin C Reagents and Four Equations on Glomerular Filtration Rate Estimations After Standardization.
Lee HS; Bae GE; Lee JE; Park HD
Ann Lab Med; 2023 Nov; 43(6):565-573. PubMed ID: 37387489
[TBL] [Abstract] [Full Text] [Related]
2. [LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR kidney tumors R.E.N.A.L. SCORE 10 and HIGHER].
Kochkin AD; Knutov AV; Sevryukov FA
Urologiia; 2020 Dec; (6):93-98. PubMed ID: 33377685
[TBL] [Abstract] [Full Text] [Related]
3. Regulation of breast cancer resistance protein and P-glycoprotein by ezrin, radixin and moesin in lung, intestinal and renal cancer cell lines.
Yano K; Okabe C; Fujii K; Kato Y; Ogihara T
J Pharm Pharmacol; 2020 Apr; 72(4):575-582. PubMed ID: 31975441
[TBL] [Abstract] [Full Text] [Related]
4. Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort.
Maskarinec G; Shvetsov YB; Conroy SM; Haiman CA; Setiawan VW; Le Marchand L
Breast Cancer Res Treat; 2019 Feb; 173(3):637-645. PubMed ID: 30367331
[TBL] [Abstract] [Full Text] [Related]
5. Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases kidney Cancer Growth.
Abu Aboud O; Chen CH; Senapedis W; Baloglu E; Argueta C; Weiss RH
Mol Cancer Ther; 2016 Sep; 15(9):2119-29. PubMed ID: 27390344
[TBL] [Abstract] [Full Text] [Related]
6. Different regulation of P-glycoprotein function between Caco-2 and Caki-1 cells by ezrin, radixin and moesin proteins.
Yano K; Otsuka K; Kato Y; Kawabata H; Ohmori S; Arakawa H; Ogihara T
J Pharm Pharmacol; 2016 Mar; 68(3):361-7. PubMed ID: 26888084
[TBL] [Abstract] [Full Text] [Related]
7. Risk of Nephrectomy in Previous Living kidney Donors.
Ordon M; Welk B; McArthur E; Lam NN; Lentine KL; Nguan C; Garg AX;
Transplantation; 2016 Jun; 100(6):1313-7. PubMed ID: 26683516
[TBL] [Abstract] [Full Text] [Related]
8. Management of Small kidney Cancers in the New Millennium: Contemporary Trends and Outcomes in a Population-Based Cohort.
Huang WC; Atoria CL; Bjurlin M; Pinheiro LC; Russo P; Lowrance WT; Elkin EB
JAMA Surg; 2015 Jul; 150(7):664-72. PubMed ID: 26017316
[TBL] [Abstract] [Full Text] [Related]
9. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.
Hakimi AA; Furberg H; Zabor EC; Jacobsen A; Schultz N; Ciriello G; Mikklineni N; Fiegoli B; Kim PH; Voss MH; Shen H; Laird PW; Sander C; Reuter VE; Motzer RJ; Hsieh JJ; Russo P
J Natl Cancer Inst; 2013 Dec; 105(24):1862-70. PubMed ID: 24285872
[TBL] [Abstract] [Full Text] [Related]
10. Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7.
Hsu YH; Lin WL; Hou YT; Pu YS; Shun CT; Chen CL; Wu YY; Chen JY; Chen TH; Jou TS
Am J Pathol; 2010 Jun; 176(6):3050-61. PubMed ID: 20395446
[TBL] [Abstract] [Full Text] [Related]
11. Podoplanin binds erm proteins to activate RhoA and promote epithelial-mesenchymal transition.
Martín-Villar E; Megías D; Castel S; Yurrita MM; Vilaró S; Quintanilla M
J Cell Sci; 2006 Nov; 119(Pt 21):4541-53. PubMed ID: 17046996
[TBL] [Abstract] [Full Text] [Related]
12. The 26S proteasome system degrades the erm transcription factor and regulates its transcription-enhancing activity.
Baert JL; Beaudoin C; Monte D; Degerny C; Mauen S; de Launoit Y
Oncogene; 2007 Jan; 26(3):415-24. PubMed ID: 16832340
[TBL] [Abstract] [Full Text] [Related]
13. Involvement of neutral endopeptidase in neoplastic progression.
Sumitomo M; Shen R; Nanus DM
Biochim Biophys Acta; 2005 Aug; 1751(1):52-9. PubMed ID: 16054017
[TBL] [Abstract] [Full Text] [Related]
14. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human.
Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y
Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226
[TBL] [Abstract] [Full Text] [Related]
